Description
DO34 analog is a triazole DAGL(α) inhibitor extracted from patent WO2017096315 A1, compound 100.
Product information
CAS Number: 2098969-71-0
Molecular Weight: 531.53
Formula: C26H28F3N5O4
Chemical Name: tert-butyl 3-benzyl-4-{4-[4-(trifluoromethoxy)phenyl]-2H-1,2,3-triazole-2-carbonyl}piperazine-1-carboxylate
Smiles: CC(C)(C)OC(=O)N1CC(CC2C=CC=CC=2)N(CC1)C(=O)N1N=C(C=N1)C1=CC=C(C=C1)OC(F)(F)F
InChiKey: ZCLTTXIIPQGUKN-UHFFFAOYSA-N
InChi: InChI=1S/C26H28F3N5O4/c1-25(2,3)38-24(36)32-13-14-33(20(17-32)15-18-7-5-4-6-8-18)23(35)34-30-16-22(31-34)19-9-11-21(12-10-19)37-26(27,28)29/h4-12,16,20H,13-15,17H2,1-3H3
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: DMSO : ≥ 105 mg/mL (197.54 mM).
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.